Isabel Cristina Céspedes | Neuropharmacology | Best Researcher Award

Published on 20/01/202520/01/2025 by Top Pharmaceutical

Isabel Cristina Céspedes | Neuropharmacology | Best Researcher Award

Assoc Prof Dr Isabel Cristina Céspedes, Escola Paulista de Medicina – UNIFESP, Brazil

Assoc. Prof. Dr. Isabel Cristina Céspedes is a prominent researcher with a focus on genetics, neuroscience, and psychobiology. She obtained her Ph.D. in Morphofunctional Sciences from the University of São Paulo in 2007, specializing in stress-related brain responses in rodents. With postdoctoral work at UNIFESP and extensive teaching experience at universities like USP and UNIP, she explores topics such as substance abuse, epigenetics, and transfusion medicine. She has contributed to numerous publications in journals like Behavioural Brain Research and The Journal of Neuroscience. Her ongoing research investigates the effects of blood transfusions and addiction disorders. 🧠🔬💉📚

Publication Profile

Google Scholar

Educational Background

Assoc. Prof. Dr. Isabel Cristina Céspedes has a distinguished academic background, holding a Ph.D. in Morphofunctional Sciences from the University of São Paulo, specializing in neurobiological responses to stress 🧠. Her postdoctoral research at the Federal University of São Paulo deepened her expertise in genetic and molecular neurobiology 🔬. With a passion for understanding the intricate mechanisms of stress at the molecular level, Dr. Céspedes has contributed significantly to the field, advancing knowledge in neurobiology and stress-related disorders. Her work continues to inspire and shape research in neuroscience and molecular biology 🧬✨.

Leadership in Academia

Dr. Céspedes is an active educator, researcher, and mentor at prestigious institutions such as UNIFESP and USP, where she has made significant contributions to the academic community 📚. With her dedication to higher education, she holds several administrative and leadership roles, guiding academic programs and playing a pivotal part in various committees 🏫💼. Her work reflects a passion for both academic excellence and student mentorship, and her leadership has helped shape the educational landscape at these esteemed institutions 🌟. Through her efforts, Dr. Céspedes continues to inspire and shape future scholars and professionals 🌱.

Research Projects

Dr. Céspedes is conducting pioneering research on the epigenetic effects of blood transfusions, aiming to enhance clinical practices and improve patient outcomes. By examining how transfusions influence gene expression, their work is providing valuable insights into patient health and long-term recovery. Dr. Céspedes’ research contributes to a deeper understanding of the molecular mechanisms involved, which could lead to more personalized medical treatments and better management of transfusion-related complications. This groundbreaking work is opening new avenues in both clinical and genetic research, offering potential advancements in healthcare. 🧬🩸🔬👩‍🔬

Research Focus

Dr. Isabel Cristina Céspedes focuses on neuroscience, particularly in the areas of neuroplasticity, anxiety, stress responses, and neurogenesis. Her research investigates how environmental factors, such as chronic stress and psychological interventions, affect the brain’s defensive responses, Fos immunoreactivity, and hippocampal neurogenesis. She has also explored the effects of substances like alcohol on brain function, including how they alter locomotion and neurocircuitry associated with reward and anxiety. Additionally, Dr. Céspedes contributes to studies on hormonal regulation, particularly cortisol, and its implications for mental health. Her work spans animal models, psychological interventions, and neurobiological mechanisms. 🧠🔬💉📚

Publication Top Notes

Chronic unpredictable mild stress alters an anxiety-related defensive response, Fos immunoreactivity and hippocampal adult neurogenesis

Physical therapy and psychological intervention normalize cortisol levels and improve vitality in women with endometriosis

Una alternativa natural para el tratamiento de la COVID-19

Effects of chronic treatment with corticosterone and imipramine on fos immunoreactivity and adult hippocampal neurogenesis

Environmental enrichment decreases avoidance responses in the elevated T-maze and delta FosB immunoreactivity in anxiety-related brain regions

The Edinger–Westphal nucleus II: Hypothalamic afferents in the rat

Acute restraint differently alters defensive responses and fos immunoreactivity in the rat brain

mRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration

Alcohol consumption increases locomotion in an open field and induces Fos-immunoreactivity in reward and approach/withdrawal-related neurocircuitries

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Published on 20/01/202522/01/2025 by Top Pharmaceutical

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Dr Michael Swedberg, Swedberg Preclinical Partner, Sweden

Dr. Michael Swedberg is a distinguished pharmacologist with extensive expertise in safety pharmacology, CNS pharmacology, gastrointestinal pharmacology, and drug abuse assessment. He has held key leadership roles, including Associate Director at AstraZeneca and founder of Swedberg Preclinical Partner AB. His global impact includes contributions to regulatory compliance, developing novel animal models, and mentoring future researchers. With a Ph.D. in discrimination learning and postdoctoral training at NIDA, Dr. Swedberg has collaborated internationally and received numerous accolades for his innovative research and leadership. His career embodies excellence in pharmacology and preclinical drug discovery. 🌍💊🔬

Publication Profile

scopus

Education

Dr. Michael Swedberg is a distinguished academic and researcher, having earned his Ph.D. in 1985 from the University of Uppsala, Sweden. His doctoral dissertation focused on “A Model of Discrimination Learning with Interoceptive Stimuli.” He completed his postdoctoral fellowship at the National Institutes of Health (NIH), specializing in addiction research at the National Institute on Drug Abuse’s Preclinical Pharmacology Branch in Baltimore, Maryland (1985–1988). Additionally, Dr. Swedberg holds a Bachelor of Social Science (B.S.Sc.) from Uppsala University, with a comprehensive background in psychology, sociology, and law. 🧠📚🎓

Professional Appointments

Dr. Michael Swedberg has had an extensive and distinguished career in pharmacology and drug discovery. From 2014 to 2021, he was the Founder and CEO of Swedberg Preclinical Partner AB in Sweden. Prior to that, he was a Partner and Consultant at The Research Network (TRN) from 2014 to 2016. His earlier career includes key roles at AstraZeneca R&D, where he served as Associate Director in Safety Pharmacology and Preclinical Development. He also held senior leadership positions at Novo Nordisk and Ferrosan. Dr. Swedberg’s journey began as a Lecturer at Mälardalen University in 1981. 🧑‍🔬💉📚

Academic Service

Dr. Michael Swedberg has made significant contributions to the field of pharmacology and neuroscience through various roles. He served as a board member for the Department of Psychology at the University of Uppsala and the Faculty of Social Sciences from 1980 to 1985. His leadership extended to chairing the Council of Graduate Students. Recognized for his service, Dr. Swedberg received awards from the Drug Abuse Liability Ad Hoc Committee and for his work with the Lilly–Novo Nordisk Muscarinic Research Collaboration. He has also been a grant evaluator for the European Union and Poland’s National Centre for Research and Development. 🌍🔬🧠

Presentations

Dr. Michael Swedberg has made significant contributions to the field of drug safety and abuse liability assessment. His research, presented at multiple prestigious meetings, includes the role of drug discrimination studies in evaluating novel compounds’ abuse potential. Notably, his work at the Safety Pharmacology Society, American College of Toxicology, and the Swedish Pharmaceutical Congress has advanced methodologies like rat self-administration and drug discrimination for psychoactive effects. His work on the interaction between mGluR5 antagonists and benzodiazepines also stands out. Swedberg’s contributions to safety pharmacology have had a lasting impact on CNS drug development and regulatory guidelines. 🧠💊

Lecturing and teaching

Dr. Michael Swedberg has delivered extensive lectures and seminars on safety pharmacology, drug abuse, and CNS risk assessment. His contributions include lectures at the American College of Toxicology, Safety Pharmacology Society, and the European Congress of Toxicologic Pathology, focusing on drug dependence, abuse liability, and CNS safety. Additionally, Swedberg has provided in-depth training on the regulatory and industrial challenges in drug development at AstraZeneca and other global platforms. His teaching spans from the biomedical program at Karolinska Institute to the University of Uppsala, covering neuropharmacology, psychopharmacology, and drug addiction. His educational materials are widely respected in the field. 🧠📚💊

Academic Supervision

Dr. Michael Swedberg has mentored numerous students at various stages of their academic careers, including graduate, Ph.D., and postdoctoral researchers. He supervised students at Umeå University, University of Uppsala, and Karolinska Institute, guiding experimental work in fields such as cannabinoid tolerance, dopamine release, and nicotine’s effects on learning. His postdoctoral supervision included projects on visual and auditory discrimination in drug testing. Swedberg’s research has been supported by multiple prestigious grants, such as the Clas Groschinsky Memorial Foundation and the Swedish Medical Research Council. His contributions have significantly advanced brain and behavior research. 🎓🧠💡

Committee Service

Dr. Michael Swedberg held several key roles at AstraZeneca, including membership in the Safety Knowledge Group for CNS and leadership in CNS GLP Safety Pharmacology Harmonization. He was also a part of multiple committees, such as the AstraZeneca Expert Advisory Group on Abuse Liability and the Cross Company Abuse Liability Consortium. Dr. Swedberg contributed to international organizations like PhRMA and CPDD, focusing on drug abuse liability. He attended professional courses in safety pharmacology, project management, and leadership, further enhancing his expertise. Additionally, he completed a teaching course at Karolinska Institute, strengthening his academic influence. 🧠💊🎓

Research Focus

Dr. Michael Swedberg’s research focuses on the pharmacology of muscarinic receptors and their potential therapeutic applications, particularly in relation to neurological and psychiatric disorders. His work has delved into muscarinic receptor agonists, with significant contributions to the understanding of their antipsychotic and antinociceptive properties. Additionally, he has explored the role of nicotinic compounds and their reinforcing effects. His research has implications for treating conditions like schizophrenia, Alzheimer’s disease, and irritable bowel syndrome. 🧠🔬💊 His studies on receptor-ligand interactions and pharmacological profiles contribute to the development of novel drugs for various neurological and gastrointestinal conditions.

Publication Top Notes

Approaches for early identification of abuse potential liability

Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse

Drug Discrimination: Use in Preclinical Assessment of Abuse Liability

AZD9272 and AZD2066: Selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects

Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions

Establishment of auditory discrimination and detection of tinnitus induced by salicylic acid and intense tone exposure in the rat

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Published on 20/01/202520/01/2025 by Top Pharmaceutical

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Prof Luisa De Cola, University of Milan and Mario Negri Institute, Italy

Prof. Luisa De Cola is an accomplished chemist known for her interdisciplinary research in supramolecular and materials chemistry, with applications in biomedical fields. She holds a Laurea in Chemistry from the University of Messina and has held prestigious positions at institutions like the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at Istituto Mario Negri, Milan. With over 400 published papers and 42 patents, she has received numerous awards, including the 2020 Gold Medal “Giulio Natta” and 2014 Chevalier de la Légion d’Honneur. 🏅🔬💡

Publication Profile

Google Scholar

Education

Prof. Luisa De Cola, a renowned scientist, earned her Laurea in Chemistry from the University of Messina in 1983. She has held various prestigious academic roles, including Post-doctoral Fellow at Virginia Commonwealth University, and visiting scientist positions at UCLA, Harvard, and MIT. From 1986 to 1990, she worked as a researcher at the National Research Council in Bologna. She later served as a Full Professor at the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at the Mario Negri Institute. 🧪🔬🌍

Experience

Prof. Luisa De Cola is a renowned academic and researcher currently serving as a Full Professor at the University of Milan, Italy, since 2020. She is also the Director of the “Materials for Health” unit at Istituto di Ricerche Farmacologiche Mario Negri in Milan. Her distinguished career includes previous roles at prestigious institutions such as the University of Amsterdam, University of Münster, and University of Strasbourg. Prof. De Cola has held notable positions, including chairing molecular photonic materials and nanoelectronics. Her research contributions span nanoelectronics, nanophotonics, and biomaterials. 🌍📚🔬👩‍🔬

Research achievements

Prof. Luisa De Cola’s research is known for its multidisciplinary approach, driven by curiosity and fundamental exploration, often with practical applications. Her work spans supramolecular and material chemistry, focusing on functional luminescent and electro-luminescent assemblies, optical and electroluminescent devices, and dynamic (breakable) materials for biomedical applications. With over 400 published papers in peer-reviewed journals (H-index = 88, over 27,000 citations on Scopus), her research has been featured in prestigious journals like Nature and Nature Chemistry. Her contributions continue to shape innovations in materials science and biomedicine. 🌟🧪🔬📚💡💉

Peer recognition

Prof. Luisa De Cola is a distinguished chemist, awarded numerous prestigious prizes throughout her career. Her accolades include the 1993 Chemistry Prize from the Accademia di Scienze Fisiche e Matematiche di Napoli, the 1995 Federchimica National Prize, and the 2009 European Research Council Advanced Grant Award (Magic). In 2011, she received the IUPAC Prize for distinguished women in chemistry, followed by the 2014 Chevalier de la Légion d’Honneur. Other honors include the 2019 Izatt–Christensen Award, 2020 Giulio Natta Gold Medal, and the 2024 Centenary Prize for Chemistry and Communication. She is also an Honorary Professor at Tianjin University and a Doctor Honoris Causa from Universidad Internacional Menéndez Pelayo. 🏆🔬🎖️🌟

Research Focus

Prof. Luisa De Cola’s research focuses on advanced materials, particularly in the development of luminescent and electrochemical systems for various applications. Her work involves the synthesis and characterization of ruthenium and osmium complexes, often in multi-component systems, exploring their electrochemical behavior, absorption spectra, and photoinduced processes. She investigates biomimetic self-assembly for imaging applications, the creation of highly luminescent lanthanide complexes, and photoinduced energy and electron transfer in dinuclear complexes. Her studies have applications in photonic devices, electroluminescence, and molecular imaging. Her work intersects chemistry, material science, and biological applications. 🔬💡🔋✨

Publication Top Notes

Ruthenium (II) and osmium (II) bis (terpyridine) complexes in covalently-linked multicomponent systems: synthesis, electrochemical behavior, absorption spectra, and …

Controlling and imaging biomimetic self-assembly

White‐light emission from an assembly comprising luminescent iridium and europium complexes

Highly luminescent, triple-and quadruple-stranded, dinuclear Eu, Nd, and Sm (III) lanthanide complexes based on bis-diketonate ligands

When self-assembly meets biology: luminescent platinum complexes for imaging applications

Photoinduced energy and electron transfer processes in rigidly bridged dinuclear Ru/Os complexes

Electroluminescent device with reversible switching between red and green emission

Jose M. Soriano | Precision Medicine | Best Researcher Award

Published on 20/01/202520/01/2025 by Top Pharmaceutical

Jose M. Soriano | Precision Medicine | Best Researcher Award

Prof Jose M. Soriano, University of Valencia, Spain

Prof. José M. Soriano is a Full Professor at the Faculty of Pharmacy, Universitat de València, specializing in food safety, toxicology, and nutrition. He holds a Ph.D. in Food Safety and Toxicology (2001) and degrees in Pharmacy (1996) and Human Nutrition and Dietetics (2018). He has led over 50 national and international projects and published 199 journal articles. With an impressive citation index of 5,263, Prof. Soriano is also Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics and has published 50 books. His research focuses on nutraceutics, food safety, and toxicology. 📚🍏🔬

Publication Profile

Google Scholar

Academic Background

Prof. José M. Soriano holds a doctorate in Food Safety and Toxicology, along with degrees in Pharmacy and Human Nutrition. With extensive experience in pharmacy, food science, and nutrition research, he is a Full Professor at Universitat de València. His expertise covers critical areas such as food safety, toxicology, and nutrition, where he contributes to advancing scientific understanding. Prof. Soriano’s work bridges academia and practical application, ensuring a deep impact on public health and safety. 🍏🔬📚

Research and Innovations

Prof. José M. Soriano is a distinguished researcher with extensive expertise in food safety, nutrition, and toxicology. He has led over 50 national and international projects, significantly advancing scientific understanding in these critical areas. With more than 5,200 citations and 199 publications in renowned journals, his work has made a lasting impact. Prof. Soriano’s involvement in over 20 consultancy and industry projects further highlights the practical application of his research. His contributions continue to shape the fields of food safety and toxicology, ensuring better public health and informed industry practices. 📚🔬🌍🥗🧬

Editorial and Collaborative Roles

Prof. José M. Soriano is a renowned expert in human nutrition and dietetics, currently serving as the Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics. Through his leadership and extensive collaborations with prestigious institutions across Africa and Asia, he actively contributes to advancing research and education in the field. Prof. Soriano’s dedication to improving global health, particularly through nutrition, has earned him recognition across continents. His work plays a significant role in fostering knowledge exchange and implementing impactful solutions in diverse healthcare settings. 🌍🍏📚💡👨‍⚕️

Professional Recognition

Prof. José M. Soriano is highly esteemed within the scientific community, evident through his memberships in prestigious organizations like the Spanish Academy of Nutrition and Dietetics and the Academy of Pharmacy of the Valencian Community. His recognition in these influential bodies reflects his significant contributions to the fields of nutrition, dietetics, and pharmacy. Through his work, Prof. Soriano has earned respect and credibility, underscoring his dedication to advancing knowledge and practices in these vital areas. His ongoing involvement with these academies is a testament to his ongoing impact and influence. 👨‍⚕️📚🏅

Research Focus

Based on the provided research publications, the individual appears to focus primarily on food safety and toxicology, with a particular interest in mycotoxins and their effects on human health. Their work spans areas like the toxicity, occurrence, and detoxification of mycotoxins such as aflatoxins, zearalenone, and fumonisins. Additionally, they have explored the mechanisms of action of sphingolipids in toxicity, food contamination, and microbiological quality in food products like lettuce and milk. This researcher is also involved in studies on obesity and nutrition, highlighting their expertise in both food toxicology and clinical nutrition. 🧪🍽️🔬🦠

Publication Top Notes

Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin

Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1

Presence of aflatoxin M1 in pasteurized milk from Morocco

Determination of aflatoxins in peanuts by matrix solid-phase dispersion and liquid chromatography

Assessment of the microbiological quality and wash treatments of lettuce served in University restaurants

Incidence of ochratoxin A in rice and dried fruits from Rabat and Salé area, Morocco

Incidence of microbial flora in lettuce, meat and Spanish potato omelette from restaurants

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Published on 20/01/202520/01/2025 by Top Pharmaceutical

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Prof Dr YORINOBU MAEDA, Fukuyama university, Japan

Prof. Dr. Yorinobu Maeda, Ph.D. (Hiroshima University, 1990), is a renowned expert in drug safety, pharmacokinetics, and infection control. As a professor at Fukuyama University and Drug Safety Director, he has advanced renal function-based dosing and prescription optimization. His contributions have earned him multiple awards, including Best Paper Awards (2001, 2005) and an Academic Contribution Award (2014) from the Japanese Society of Pharmaceutical Health Care and Sciences. With a strong academic and clinical impact, Dr. Maeda is a leading figure in pharmaceutical advancements, ensuring better patient safety and treatment efficacy. 🏅🔬

Publication Profile

scopus

Educational and Professional Background

Prof. Dr. Yorinobu Maeda has a distinguished background in pharmaceutical sciences, earning his Ph.D. from Hiroshima University in 1990 🎓. His expertise spans infection control, hospital pharmacy specialization, and drug safety leadership, reflecting his dedication to pharmaceutical advancements 💊. With leadership roles in major hospitals 🏥 and an esteemed position as a professor at Fukuyama University 🎓, he has made significant academic and practical contributions to the field. His work continues to shape the future of pharmacy, ensuring patient safety and advancing healthcare practices for better medical outcomes 🌍🔬.

Contributions to Pharmaceutical Sciences

Prof. Dr. Yorinobu Maeda has made significant contributions to pharmaceutical sciences, particularly in drug safety, pharmacokinetics, and dosage optimization 💊🔬. His research focuses on infection control 🦠, renal function-based dosing 🏥, and improving prescription practices, directly enhancing patient safety and treatment efficacy 👨‍⚕️✅. As a Drug Safety Director, he plays a crucial role in advancing pharmaceutical practices, ensuring medications are used effectively and safely. His dedication to optimizing drug therapy and refining medical protocols continues to have a lasting impact on healthcare, improving outcomes for patients worldwide 🌍💉.

Awards and Recognitions

Prof. Dr. Yorinobu Maeda has made remarkable contributions to the field of pharmaceutical healthcare, earning numerous prestigious accolades from the Japanese Society of Pharmaceutical Health Care and Sciences. His achievements include the Best Paper Awards in 2001 and 2005 🏆, as well as the esteemed Academic Contribution Award in 2014 🎓. These honors highlight his dedication to advancing research and implementing pharmacokinetic principles to enhance patient safety and care 🩺. Dr. Maeda’s work stands as a testament to his unwavering commitment to improving healthcare standards and fostering innovation in pharmaceutical sciences. 🌟

Research Focus

Professor Dr. Yorinobu Maeda is an eminent researcher specializing in pharmaceutical sciences, with a primary focus on drug bioavailability, prodrug development, and therapeutic drug monitoring. His work spans areas such as drug absorption, small intestinal bacterial overgrowth diagnosis, and managing adverse drug reactions. Notable research includes the impact of metal ions on drug efficacy and innovative prodrug strategies. Through collaborative studies, he contributes to optimizing drug delivery systems and clinical pharmacotherapy, enhancing patient safety and treatment outcomes. 🧪💊

Publication Top Notes

5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats

Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline

Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth

Ester Prodrugs of Levofloxacin to Prevent Chelate Formation in Presence of Aluminium Ion

Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats

Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant

Guidelines for therapeutic drug monitoring of cardiovascular drugs clinical use of blood drug concentration monitoring (Jcs 2015) ― digest version ―

Dosage adjustment of dabigatran etexilate based on creatinine clearance in patients with cardioembolic stroke or atrial fibrillation

Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy

H.G. Parsa | Regulatory Affairs | Best Researcher Award

Published on 20/01/202522/01/2025 by Top Pharmaceutical

H.G. Parsa | Regulatory Affairs | Best Researcher Award

Dr H.G. Parsa, University of Denver, United States

Dr. H.G. Parsa is a distinguished scholar in hospitality and business management, with a Ph.D. from Virginia Tech. He has held prominent positions, including Barron Hilton Chair in Lodging at the University of Denver. His research spans corporate social responsibility, sustainability, revenue management, and entrepreneurship. Dr. Parsa has earned multiple awards, including the Hospitality Educator of the Year in Ohio and served as a keynote speaker globally. He is a visiting professor at prestigious institutions worldwide. His expertise is sought by top organizations like Marriott and McDonald’s. He’s also an advisory board member for the Hispanic Restaurant Association. 🌍📚🏨🍴

Publication Profile

Scopus

Education

Dr. H.G. Parsa holds a Ph.D. from Virginia Tech, where he won the International Franchise Association Research Competition for his dissertation on “Exploratory Investigation of Organization Power, and Its Impact on Strategy Implementation and Firm Performance in Hospitality Franchise Systems.” He earned his M.S. from the University of Arkansas and M.Sc. and B.Sc. (Honors) from Osmania University, India. Dr. Parsa also completed Business Management coursework at the University of Central Oklahoma. His research is guided by esteemed advisors, including Dr. Mahmood A. Khan and Dr. James R. Brown. 📚🏆🎓

International Recognition

Dr. H.G. Parsa is an internationally recognized expert in hospitality education and research, with a global impact reflected in his teaching appointments and collaborations across various countries. His extensive experience includes visiting professorships in France 🇫🇷, Vietnam 🇻🇳, India 🇮🇳, and many more, contributing to the development of hospitality programs worldwide. Dr. Parsa’s research focuses on advancing the field through cross-cultural perspectives and innovative educational strategies. His global presence and commitment to enhancing hospitality education have earned him recognition as a leading figure in the academic community 🌍🎓. His work continues to shape the future of hospitality studies.

Awards and Honors

Dr. H.G. Parsa is widely recognized as a leading expert in his field, having been nominated for prestigious awards such as the Willie McCool Breakthrough Award. He was also a finalist for the Fulbright and Nehru-Fulbright Distinguished Chair Awards, highlighting his significant contributions to academia. In addition to these accolades, Dr. Parsa has been invited as a keynote speaker at several international conferences, showcasing his expertise and global recognition. These achievements reflect his dedication and impact, positioning him as a respected figure in his professional community. 🏅🌍🎤📚

Experience

Dr. H.G. Parsa is a distinguished academic and visiting professor with extensive international experience. He has held teaching roles at renowned institutions such as Vin University (Vietnam), Institut Paul Bocuse (France), University of Southern California (USA), and several universities across India, Taiwan, and Europe. Currently, Dr. Parsa serves as the Barron Hilton Chair in Lodging & Professor at the University of Denver’s Fritz Knoebel School of Hospitality Management. He is also an Associate Editor for prestigious journals like the Journal of Hospitality and Tourism Research and Cornell Hospitality Management. 🌍📚🍴✈️🎓

Research Contribution

Dr. H.G. Parsa’s research focuses on key areas of business and hospitality, including Corporate Social Responsibility (CSR), green practices, and sustainability 🌱. His work also explores revenue management, pricing strategies, and revenue analytics in hospitality 🍽️📊. Additionally, he delves into the entrepreneurship of restaurant ventures, analyzing macro and micro factors contributing to restaurant failures 🍴💡. His studies extend to consumer behavior, exploring restaurant attributes and their influence on willingness to pay and patronize 🏷️🍔. Dr. Parsa is also interested in marketing strategies, branding, franchising, and tracking changing American food habits 🍔📉.

Presentations

Dr. H.G. Parsa has contributed extensively to hospitality and tourism research. His award-winning case studies include Swachh Bharath Campaign and the Indian Tourism Industry (2019), and Hospitality with a Heart and Soul (2014), which won the Best Case Research Award. He has also co-authored impactful works, such as Chipotle Mexican Grill: A Sustainability Champion Going Global with China (2018). Dr. Parsa has presented at prominent conferences, including the Euro CHIRE and Revenue Management Conferences, addressing topics like restaurant revenue performance, classification frameworks, and the impact of CSR on consumer behavior. 🌍🏆🍽️📚

Publication Top Notes

Hedonic and utilitarian motivations and the role of trust in using food delivery apps: an investigation from a developing economy

Hotels and shared economy accommodations: an analysis of business traveler preferences

The Criticality of Public Policy in Hospitality and Tourism Research

Airbnb and Business Travelers: A Prospect Theory Explanation

Why Restaurants Fail? Part V: Role of Economic Factors, Risk, Density, Location, Cuisine, Health Code Violations and GIS Factors

New Classification System for the U.S. Restaurant Industry: Application of Utilitarian and Hedonic Continuum Model

Yanik Akin | Pharmacology | Best Researcher Award

Published on 18/01/202518/01/2025 by Top Pharmaceutical

Yanik Akin | Pharmacology | Best Researcher Award

Mr Yanik Akin, Laboratory of biomathmatic and forest estimations, Benin

Yanik Akin is a PhD candidate in Biometry and Ecological Modeling at the University of Abomey-Calavi, Benin. He holds an MSc in Biostatistics and a BSc in Agronomic Science. Yanik is skilled in data analysis using Excel, KoBoCollect, and R. He has served as an external collaborator and consultant for various research projects. He teaches statistics at the National University of Agriculture, Benin. Yanik has published extensively on tropical fuelwood trees, plant communities, and phenotypic variation. His research focuses on climate, disturbance, and population dynamics. He has received prestigious grants and fellowships. 📊🌱📚🌍

Publication Profile

Scopus

Academic Excellence

Mr. Yanik Akin is a dedicated scholar currently in the defense process of his Ph.D. in Biometry and Ecological Modeling at the University of Abomey-Calavi, Benin, with a project focused on the climate, disturbance, and population dynamics of tropical fuelwood trees 🌱🌍. He earned a Master’s in Biostatistics in 2018 from the same university, where he researched distance sampling techniques in plant communities 📊🌳. Earlier, he completed his Bachelor’s in Agronomic Science, specializing in the management of natural resources, at the University of Parakou, Benin, in 2012 🎓🌿. His work continues to contribute to environmental research and sustainability.

Professional Service

Yanik Akin has a diverse academic and professional background in data analysis and statistics. From 2016 to 2019, he worked as an external collaborator and data analyst at the National Institute of Agronomic Research of Benin (INRAB). Since 2021, he has been teaching statistics at the School of Science and Techniques for the Conservation and Transformation of Agricultural Products, and at the Faculty of Science and Technology at the National University of Agriculture, Benin. Additionally, Yanik has served as an independent consultant in research methodology and data analysis from 2017 to 2024. 📊📚💻🌾

Training and Seminars

Mr. Yanik Akin actively participates in seminars and scientific meetings, both regionally and nationally, showcasing his dedication to staying updated in his field. His commitment to knowledge sharing is evident as he engages with experts and peers, exchanging insights and experiences. These platforms offer him an invaluable opportunity to present his groundbreaking work, fostering collaboration and expanding the impact of his research. Through these interactions, Mr. Akin continues to push the boundaries of his discipline, contributing to scientific progress and establishing himself as a respected figure in his field. 📚💡🎤🌍

Grants and Recognition

Mr. Yanik Akin has earned recognition in the research community through the receipt of competitive grants, including the prestigious Excellence Grant from CEA-SMIA and the DAAD Fellowship. These honors highlight his strong standing and the confidence esteemed organizations have in his research capabilities. The grants reflect his ability to secure funding for impactful and innovative projects. His success in obtaining such funding not only underscores his dedication and expertise but also showcases his potential to contribute significantly to his field. 🎓💡🏆🔬🌍

Research Focus

Mr. Yanik Akin’s research focuses on environmental changes, agricultural sustainability, and the impact of human activities on tropical ecosystems. His studies explore how anthropogenic disturbances and climate change interact to influence demographic trade-offs in fuelwood tree species, as well as phenotypic variation in crops such as the desert date and Bambara groundnut. Additionally, he investigates food safety and risks related to traditional food practices, like the street-vended Gbeli from cassava. His work combines ecology, agriculture, genetics, and public health, aiming to improve understanding and management of natural resources and promote sustainable agricultural practices. 🌱🌍🌾🌡️

Publication Top Notes

Chronic anthropogenic disturbance and climate synergistically shape demographic trade-offs in a tropical fuelwood tree

Farmer-perceived phenotypic variation and preferences reveal potential for multi-traits selection in the desert date Balanites aegyptiaca (L.) Delile in Benin

Diversity and phenotypic characterization of Bambara groundnut Vigna subterranea (L. Verdc.) in Benin

Knowledge, Hygienic Practices, and Toxi-Infectious Risks Associated with Ready-to-Eat Gbeli: A Particular Chip Derived from Cassava (Manihot esculenta Crantz) Tuber Vended in Streets of Abomey-Calavi Municipality, Benin

Mathieu MELCZER | Drug Safety and Risk Management | Best Researcher Award

Published on 18/01/202518/01/2025 by Top Pharmaceutical

Mathieu MELCZER | Drug Safety and Risk Management | Best Researcher Award

Mr Mathieu MELCZER, INRS, France

Mathieu Melczer is a skilled researcher with a strong background in chemical analysis and bio-analysis. He holds an engineering degree in chemistry from the Conservatoire National des Arts et Métiers (2019) and a professional license in water and wastewater treatment from the University of Paris Sud (2006). Currently, he works as a study officer at INRS, focusing on toxicology and biometrics. His experience spans developing analytical methods like ICP-MS, HPLC, and atomic absorption, along with project management and research valorization. He has authored multiple publications on occupational exposure, bio-monitoring, and metal analysis. 🧪🔬📊💼

Publication Profile

Orcid

Educational Background

Mathieu Melczer holds a prestigious Diplôme d’ingénieur in Chemistry from the Conservatoire National des Arts et Métiers (2019) 🏅. With specialized expertise in chemical analysis and bio-analysis 🧪, he has also earned professional degrees in water treatment, waste analysis, and chemistry 💧🔬. His diverse qualifications reflect a comprehensive training across various domains of chemistry, making him a well-rounded expert in the field 🌱. Mathieu’s commitment to excellence and his broad skill set contribute significantly to his professional achievements 🌍✨.

Professional Experience

Mathieu Melczer has over a decade of experience in toxicology, biomonitoring, and analytical chemistry at the Institut National de Recherche et de Sécurité (INRS) 🧪🔬. He has managed numerous research projects, conducted advanced laboratory studies, and developed innovative analytical methods, including ICP-MS, HPLC, and Atomic Absorption Spectroscopy 💡🔍. Mathieu’s work showcases his expertise in both independent research and team leadership 👨‍🔬🤝. His capacity to manage teams, interact with clients, and oversee complex projects highlights his strong collaborative and managerial skills 💼🌟.

Professional Development

Mathieu Melczer has shown continuous professional growth through his commitment to specialized training. He has undertaken advanced courses in statistical analysis 📊, analytical chemistry techniques such as ICP-MS and metabolomics 🔬, and has honed his knowledge of good clinical practices 🏥. His dedication to expanding his expertise in these areas reflects a strong foundation for his career development. Mathieu’s focus on cutting-edge research methods and adherence to clinical standards highlights his versatility and commitment to excellence in the field, positioning him as a valuable asset in his professional journey. 📚🔍

Research Focus

Mathieu Melczer’s research focuses on the field of analytical chemistry, with a particular emphasis on environmental and occupational health. His work often involves multielement analysis using advanced techniques like inductively coupled plasma tandem mass spectrometry (ICP-MS) to assess metal exposure in biological samples, such as red blood cells and urine. His studies include the biomonitoring of toxic metals like chromium and beryllium, highlighting their effects on human health. Melczer also explores the mineralization of nanoparticles and their detection in tissues. His research aims to improve understanding of metal toxicity and its impact on human health and the environment. 🧪⚗️🔬💉🌍

Publication Top Notes

Multielement analysis of single red blood cells by single cell – inductively coupled plasma tandem mass spectrometry

88 Occupational Exposure to Metals Among Battery Recyclers in France: Biomonitoring and External Dose Measurements

Evaluation of chromium in red blood cells as an indicator of exposure to hexavalent chromium: An in vitro study

Mineralization of TiO2 nanoparticles for the determination of titanium in rat tissues

Beryllium determination in urine at nanogram level for biomonitoring purpose

conclusion

Mathieu Melczer is a distinguished researcher whose exceptional qualifications, professional achievements, and impactful research have established him as a leader in toxicology and environmental health. 🌍🔬 His work holds immense significance, addressing critical issues in these fields and contributing to the advancement of scientific knowledge. 📚✨ Mathieu’s dedication to innovation and excellence is evident in his valuable contributions, which have been widely recognized and praised. 🏆👏 Committed to continuous development, he inspires peers and students alike with his expertise and passion. 🔥🎓 Mathieu’s outstanding accomplishments make him a deserving candidate for the prestigious Best Researcher Award. 🥇

Nazia chaudhary | Drug Repurposing | Young Scientist Award

Published on 18/01/202518/01/2025 by Top Pharmaceutical

Nazia chaudhary | Drug Repurposing | Young Scientist Award

Dr Nazia chaudhary, ACTREC, TMC, India

Dr. Nazia Chaudhary is a distinguished cancer researcher 🧬 with a Ph.D. focused on pathways promoting tumorigenesis and therapy resistance upon Plakophilin 3 loss 🎗️. Her academic journey includes notable projects on protease-producing thermophiles 🌡️ and mitochondrial function ⚡. She co-holds patents on Lipocalin-2 antibodies 🧪 and has published extensively in high-impact journals 📚, including Redox Biology and FEBS Letters. A DST Inspire Faculty Fellow (2023) 🌟, she has received numerous awards, including the Vaishno Endowment Prize 🏆 and Mahindra Talent Scholarships 🎓. Dr. Chaudhary’s impactful work has been presented globally 🌍, including at Cold Spring Harbor Laboratory, New York.

Publication Profile

Orcid

Academic Project

Dr. Nazia Chaudhary is an accomplished researcher with a Ph.D. focused on the project “Characterization of pathways that promote tumorigenesis, radio, and chemo-resistance upon Plakophilin 3 loss.” 💡🧬 She worked on isolating and characterizing protease and antimicrobial-producing thermophiles from Ganeshpuri hot springs at St. Xavier’s College, Mumbai (Jan-Apr 2015). 🌋🔬 Additionally, she contributed to the external project “MKT1 Dependent Regulation of Mitochondrial Function” at Tata Institute of Fundamental Research (May-Aug 2014). 🧪⚙️ Her EXSP project involved isolating and screening thermophilic Actinomycetes for enzymes with industrial importance. 🔍🌡️ Dr. Chaudhary’s diverse research showcases her expertise in microbiology and biotechnology. 🌟

Conference Attended

Dr. Nazia Chaudhary has showcased her research on various esteemed platforms. She presented a poster titled “Screening of Thermophilic Actinomycetes Capable of Producing Enzymes of Industrial Importance” at the Shri Sajjan Gupta Memorial Trophy for Excellence in Biological Science, held on December 11, 2012, at G.N. Khalsa College. Another poster, “Increase in Lipocalin2 Expression Upon Plakophilin3 Loss Confers Chemo and Radioresistance to Tumor Cells,” was presented at the Environmental Mutagen Society of India (EMSI) conference in January 2018 at BARC, Mumbai, and at the prestigious Mechanisms & Models of Cancer meeting in August 2018 at Cold Spring Harbor Laboratory, New York. 🌟🔬📊

Awards and Honors

Dr. Nazia Chaudhary is a distinguished scholar with multiple accolades. She was awarded the prestigious DST Inspire Faculty Award in 2023 and recognized for her research on lipocalin 2 expression and chemo-radiotherapy resistance at the 14th Indo-Australian Biotechnology Conference. She served as a Board of Studies member for Sophia College’s Zoology Department (2018-2021). Throughout her academic journey, she earned various honors, including the Ramidevi Murlidhar Jalan Award 🏆, Saifee Education Aid Scholarship 🎓, and the Mahindra Search for Talent Scholarship 🌟. Her exceptional performance also earned her the Mrs. A. Varghese Prize 🥇 and several other prestigious scholarships and awards.

Patent

Dr. Nazia Chaudhary, along with Sorab N. Dalal, Manjula Das, Sujan K. Dhar, and Smitha P. K., contributed to the development of “Antibodies Against Lipocalin-2 and Use Thereof.” This groundbreaking research led to two key milestones. The first was the PCT application (PCT/IN2020/051068) with publication no. WO/2021/137254 on July 8, 2021. The second was the Indian patent (DBT Indian Patent no: 202021000274) granted on July 30, 2021, published in the Patent Office journal no. 31/2021. These innovations hold significant potential for medical advancements. 🧬💉🧪🔬

Research Focus

Dr. Nazia Chaudhary’s research focuses on the molecular mechanisms of cancer progression, therapy resistance, and invasion, particularly in triple-negative breast cancer (TNBC) and colorectal cancer. She investigates the role of Lipocalin 2 (LCN2) in regulating cellular processes like focal adhesion formation, actin glutathionylation, and ferroptosis inhibition, which are critical for tumor cell migration and resistance to treatment. Her work explores the interplay between signaling pathways, such as Src activation and glutathione metabolism, to uncover potential vulnerabilities in cancer cells. 🧬💥💉🧪🧫

Publication Top Notes

LCN2 promotes focal adhesion formation and invasion by stimulating Src activation

EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI

GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition

Lipocalin 2 inhibits actin glutathionylation to promote invasion and migration.

The Role of Lipocalin 2 (LCN2) in Regulating Ferroptosis and Therapy Resistance

Joonsik Jo | Formulation Science | Best Researcher Award

Published on 17/01/202517/01/2025 by Top Pharmaceutical

Joonsik Jo | Formulation Science | Best Researcher Award

Mr Joonsik Jo, The Seoul Institute, South Korea

Mr. Joonsik Jo is a distinguished researcher in Transportation Planning & Engineering with expertise in using Explainable Artificial Intelligence (XAI) to analyze the relationship between pedestrian volume and air quality 🌍🚶. He holds a Master’s and Bachelor’s degree in Transportation Engineering from the University of Seoul 🎓. His impactful projects include public transportation feasibility studies and AI-driven vehicle management systems 🚆🤖. Mr. Jo’s publication in Clean Technologies and Environmental Policy and his Best Paper Presentation Award at the Korean Society of Transportation highlight his significant contributions to sustainable urban mobility 🌱.

Publication Profile

scopus

Educational Background

Mr. Joonsik holds a Master’s degree in Transportation Engineering from the University of Seoul, where his research focused on the intersection of artificial intelligence and transportation systems 🤖🚗. This solid academic foundation is supported by his Bachelor’s degree in Transportation Engineering from the same institution, showcasing his long-standing commitment to the field 📚🎓. His innovative approach to research and dedication to advancing transportation technologies makes him a standout figure in his area of expertise 🌟. Mr. Jo’s work combines the principles of engineering with cutting-edge AI, contributing to the evolution of smart transportation systems and sustainable urban mobility 🚀.

Awards and Recognition

Mr. Joonsik Jo has been honored with the Best Paper Presentation Award at the 87th Conference of the Korean Society of Transportation 🚗📚. This prestigious recognition further underscores the exceptional quality and impact of his research in the field of transportation studies. By effectively communicating complex ideas, Mr. Jo has demonstrated his ability to present innovative insights that contribute significantly to the academic community. His achievement highlights both his dedication to advancing knowledge and his skill in conveying intricate concepts with clarity 🎤🏆. This award serves as a testament to his hard work and valuable contributions to the transportation sector.

Employment History

Mr. Joonsik Jo is currently pursuing his Master’s degree in Transportation Engineering at the University of Seoul 🎓🚗. As a dedicated student, he is gaining advanced knowledge and expertise in the field of transportation, focusing on developing innovative solutions to improve infrastructure and systems. His academic journey at a prestigious institution like the University of Seoul reflects his commitment to excellence in transportation engineering. By immersing himself in research and coursework, Mr. Jo is building a strong foundation to contribute to the future of sustainable and efficient transportation solutions 🌍🔧. His passion for the field drives his continuous growth and success.

Research Projects

Mr. Joonsik Jo has made significant contributions to several high-impact research projects, focusing on urban transportation systems, sustainability, and efficiency 🌍🚇. His work on the Feasibility Study and Commercialization Plan for Public Transportation in the Uiwang-Gunpo-Ansan Area, as well as the Traffic Demand & Pedestrian Flow Estimation for the GTX Uijeongbu Station Transfer Center Construction Project, showcases his dedication to improving public transportation planning and infrastructure 🏙️🚶‍♂️. Additionally, Mr. Jo’s research on detecting MERS virus spread in public transport and developing an Autonomous Shared Vehicle Management System using AI deep learning techniques highlights his innovative, multidisciplinary approach to solving real-world challenges 🤖💡.

Published Work

Mr. Joonsik Jo has made a remarkable contribution to the field through his publication in Clean Technologies and Environmental Policy (SCIE journal) 🌿📖. His research explores the relationship between air quality and walkability using cutting-edge Explainable AI (XAI) techniques 🌬️🤖. This innovative approach allows for a deeper understanding of environmental and transportation issues, which is vital for creating sustainable and livable cities 🏙️💚. By applying XAI to these complex challenges, Mr. Jo is helping to pave the way for smarter urban planning and more effective solutions to improve both air quality and pedestrian infrastructure.

Research Focus

Mr. Joonsik Jo’s research primarily focuses on urban transportation systems, environmental impact, and the use of artificial intelligence (AI) for data analysis in transportation planning. His work includes topics such as predicting passenger congestion in subways 🚇, travel demand management to mitigate climate change 🌍, and the impact of transportation on air quality 🌫️. Additionally, he explores the relationship between air quality and walkability 🏙️ using explainable AI techniques. His contributions also include environmental comparisons between different public transport systems, such as super bus rapid transit and trams 🚍🚋. His research aims to enhance sustainable urban development and improve environmental quality.